Biophysical Properties of Novel 1-Deoxy-(Dihydro)ceramides Occurring in Mammalian Cells
- 1 December 2014
- journal article
- Published by Elsevier in Biophysical Journal
- Vol. 107 (12) , 2850-2859
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumorsInvestigational New Drugs, 2012
- Effect of ceramide structure on membrane biophysical properties: The role of acyl chain length and unsaturationBiochimica et Biophysica Acta (BBA) - Biomembranes, 2011
- Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of SphingolipidomicsChemical Reviews, 2011
- Many CeramidesJournal of Biological Chemistry, 2011
- A Mouse Macrophage LipidomeJournal of Biological Chemistry, 2010
- Kdo2-Lipid A, a TLR4-specific Agonist, Induces de Novo Sphingolipid Biosynthesis in RAW264.7 Macrophages, Which Is Essential for Induction of AutophagyJournal of Biological Chemistry, 2010
- Mutations in the SPTLC2 Subunit of Serine Palmitoyltransferase Cause Hereditary Sensory and Autonomic Neuropathy Type IThe American Journal of Human Genetics, 2010
- Coexistence of Immiscible Mixtures of Palmitoylsphingomyelin and Palmitoylceramide in Monolayers and BilayersBiophysical Journal, 2009
- Ceramide Synthase Inhibition by Fumonisin B1 Causes Accumulation of 1-DeoxysphinganineJournal of Biological Chemistry, 2009
- The marine sphingolipid-derived compound ES 285 triggers an atypical cell death pathwayApoptosis, 2006